Brookfield Asset Management - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 124 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
Brookfield Asset Management ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q2 2022$5,190,000
-25.2%
1,915,000
-17.7%
0.02%
-15.4%
Q1 2022$6,938,000
+40.2%
2,328,054
+82.9%
0.03%
+36.8%
Q4 2021$4,950,0001,272,5890.02%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 3,332,616$10,431,0002.35%
Think Investments LP 2,000,000$6,260,0001.16%
RTW INVESTMENTS, LP 5,978,355$18,712,0000.45%
COWEN AND COMPANY, LLC 472,649$1,479,0000.24%
CADENCE CAPITAL MANAGEMENT LLC 50,736$159,0000.04%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 41,700$131,0000.04%
Hudson Bay Capital Management LP 710,000$2,222,0000.03%
Ikarian Capital, LLC 115,000$360,0000.03%
MIRABELLA FINANCIAL SERVICES LLP 52,892$166,0000.02%
Secure Asset Management, LLC 10,000$31,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders